Cost utility analysis of the SQ(®) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting

BACKGROUND: Asthma affects an estimated 300 million people worldwide with the condition associated with significant healthcare utilisation costs and a large impact on patient quality of life. The SQ(®) HDM SLIT-tablet (ACARIZAX(®), Hørsholm, Denmark) is a sublingually administered allergy immunother...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Allergy
Main Authors: Hahn-Pedersen, J., Worm, M., Green, W., Andreasen, J. Nørgaard, Taylor, M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Brief Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5015209/
https://ncbi.nlm.nih.gov/pubmed/27610217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-016-0127-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados